Asperger syndrome cost-effectiveness of therapy
|
Asperger Syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Asperger syndrome cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Asperger syndrome cost-effectiveness of therapy |
|
Risk calculators and risk factors for Asperger syndrome cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shakiba Hassanzadeh, MD[2]
Overview
Based on a prevalence of 1.1 % for autism spectrum disorder (ASD) in the US, the economic burden for ASD has been estimated to be $268.2991 billion (1.467% of GDP) and $460.8002 billion (1.649% of GDP) in 2015 and 2025 respectively.[1]
Cost-Effectiveness of Therapy
Based on a prevalence of 1.1 % for autism spectrum disorder (ASD) in the US, the economic burden for ASD has been estimated to be $268.2991 billion (1.467% of GDP) and $460.8002 billion (1.649% of GDP) in 2015 and 2025 respectively.[1]
References
- ↑ 1.0 1.1 Leigh JP, Du J (2015). "Brief Report: Forecasting the Economic Burden of Autism in 2015 and 2025 in the United States". J Autism Dev Disord. 45 (12): 4135–9. doi:10.1007/s10803-015-2521-7. PMID 26183723.